Sinha R, Pradhan S, Raut S, Banerjee S, Sarkar S, Akhtar S
Pediatr Nephrol. 2024; 40(4):995-1004.
PMID: 39729126
DOI: 10.1007/s00467-024-06619-8.
Larkins N, Hahn D, Liu I, Willis N, Craig J, Hodson E
Cochrane Database Syst Rev. 2024; 11:CD002290.
PMID: 39513526
PMC: 11544715.
DOI: 10.1002/14651858.CD002290.pub6.
Hahn D, Samuel S, Willis N, Craig J, Hodson E
Cochrane Database Syst Rev. 2024; 8:CD001533.
PMID: 39171624
PMC: 11339925.
DOI: 10.1002/14651858.CD001533.pub7.
Cason R, Chambers E, Tu T, Chryst-Stangl M, Huggins K, Lane B
Front Pediatr. 2023; 11:1248733.
PMID: 37868272
PMC: 10588181.
DOI: 10.3389/fped.2023.1248733.
Ji B, Liu J, Yin Y, Xu H, Shen Q, Yu J
Cell Death Dis. 2023; 14(9):601.
PMID: 37689694
PMC: 10492865.
DOI: 10.1038/s41419-023-06124-0.
Adult survivors of childhood-onset steroid-dependent and steroid-resistant nephrotic syndrome treated with cyclosporine: a long-term single-center experience.
Takemasa Y, Fujinaga S, Nakagawa M, Sakuraya K, Hirano D
Pediatr Nephrol. 2023; 39(2):473-482.
PMID: 37608237
DOI: 10.1007/s00467-023-06108-4.
Rapid diagnosis of membranous nephropathy based on serum and urine Raman spectroscopy combined with deep learning methods.
Zhang X, Song X, Li W, Chen C, Wusiman M, Zhang L
Sci Rep. 2023; 13(1):3418.
PMID: 36854769
PMC: 9974944.
DOI: 10.1038/s41598-022-22204-1.
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Lucchetti L, Gatto A, Gianviti A, Vivarelli M, Emma F, Massella L
Pediatr Nephrol. 2022; 38(7):2101-2106.
PMID: 36434353
DOI: 10.1007/s00467-022-05824-7.
Spontaneous remission of idiopathic minimal change disease in a cat.
Broadbridge C, Hall H, McCallum K
JFMS Open Rep. 2022; 8(2):20551169221131261.
PMID: 36389213
PMC: 9643767.
DOI: 10.1177/20551169221131261.
Assessment of Brain-Derived Neurotrophic Factor (BDNF) Concentration in Children with Idiopathic Nephrotic Syndrome.
Badenski A, Badenska M, Swietochowska E, Didyk A, Morawiec-Knysak A, Szczepanska M
Int J Mol Sci. 2022; 23(20).
PMID: 36293164
PMC: 9603999.
DOI: 10.3390/ijms232012312.
Long-Term Study in Children with Steroid-Resistant Nephrotic Syndrome Progressing to End-Stage Renal Disease.
Popa L, Balgradean M, Croitoru A
Maedica (Bucur). 2022; 17(2):271-276.
PMID: 36032622
PMC: 9375901.
DOI: 10.26574/maedica.2022.17.2.271.
Corticosteroid therapy for nephrotic syndrome in children.
Hahn D, Samuel S, Willis N, Craig J, Hobson E
Cochrane Database Syst Rev. 2022; (8):CD001533.
PMID: 35659203
PMC: 8094227.
DOI: 10.1002/14651858.CD001533.pub6.
Childhood Idiopathic Nephrotic Syndrome: Does the Initial Steroid Treatment Modify the Outcome? A Multicentre, Prospective Cohort Study.
Pasini A, Bertulli C, Casadio L, Corrado C, Edefonti A, Ghiggeri G
Front Pediatr. 2021; 9:627636.
PMID: 34307246
PMC: 8295604.
DOI: 10.3389/fped.2021.627636.
Immunological Impact of a Gluten-Free Dairy-Free Diet in Children With Kidney Disease: A Feasibility Study.
Perez-Saez M, Uffing A, Leon J, Murakami N, Watanabe A, Borges T
Front Immunol. 2021; 12:624821.
PMID: 34149688
PMC: 8208082.
DOI: 10.3389/fimmu.2021.624821.
AGREEing on clinical practice guidelines for idiopathic steroid-sensitive nephrotic syndrome in children.
Alhasan K, Al Khalifah R, Aloufi M, Almaiman W, Hamad M, Abdulmajeed N
Syst Rev. 2021; 10(1):144.
PMID: 33971949
PMC: 8112064.
DOI: 10.1186/s13643-021-01666-w.
Update on the treatment of steroid-sensitive nephrotic syndrome.
Zotta F, Vivarelli M, Emma F
Pediatr Nephrol. 2021; 37(2):303-314.
PMID: 33665752
DOI: 10.1007/s00467-021-04983-3.
Comprehensive Review of Steroid-Sensitive Nephrotic Syndrome Genetic Risk Loci and Transcriptional Regulation as a Possible Mechanistic Link to Disease Risk.
Stone H, Parameswaran S, Eapen A, Chen X, Harley J, Devarajan P
Kidney Int Rep. 2021; 6(1):187-195.
PMID: 33426398
PMC: 7783560.
DOI: 10.1016/j.ekir.2020.09.048.
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Larkins N, Liu I, Willis N, Craig J, Hodson E
Cochrane Database Syst Rev. 2020; 4:CD002290.
PMID: 32297308
PMC: 7160055.
DOI: 10.1002/14651858.CD002290.pub5.
Prediction of Short- and Long-Term Outcomes in Childhood Nephrotic Syndrome.
Carter S, Mistry S, Fitzpatrick J, Banh T, Hebert D, Langlois V
Kidney Int Rep. 2020; 5(4):426-434.
PMID: 32280840
PMC: 7136435.
DOI: 10.1016/j.ekir.2019.12.015.
Rituximab experience in children with nephrotic syndrome: what have we observed differently.
Girisgen I, Yuksel S, Pekal Y
Turk Pediatri Ars. 2020; 55(1):60-66.
PMID: 32231451
PMC: 7096562.
DOI: 10.14744/TurkPediatriArs.2019.76148.